| Angel E Mier Hicks, MD | |
|
5206 Research Dr, San Antonio, TX 78240-5251 | |
| (210) 595-5300 | |
| (210) 595-5301 |
| Full Name | Angel E Mier Hicks |
|---|---|
| Gender | Male |
| Speciality | Medical Oncology |
| Experience | 12 Years |
| Location | 5206 Research Dr, San Antonio, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376984807 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Methodist Hospital | San antonio, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Texas Oncology Pa | 5395658934 | 855 |
News Archive
Researchers at the Partners AIDS Research Center at Massachusetts General Hospital (PARC-MGH) may have discovered a second molecular "switch" responsible for turning off the immune system's response against HIV.
An international team of researchers led by scientists at the Virginia Bioinformatics Institute at Virginia Tech have sequenced the genome of an Amerindian strain of the gastric bug Helicobacter pylori, confirming the out-of-Africa migration of this bacterial stowaway to the New World. Experiments in animals have highlighted how specific genes in the bacterial strain may be crucial to the onset of inflammation and disease.
Contrary to popular belief, there is no connection between lunar phases and the incidence of psychological problems. This is the conclusion reached by a team of researchers directed by Professor Genevi-ve Belleville of Universit- Laval's School of Psychology after having examined the relationship between the moon's phases and the number of patients who show up at hospital emergency rooms experiencing psychological problems.
"Understanding cancer heterogeneity could further reduce chemo use," says cancer research expert Antonio Giordano, MD, PhD, Director of the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University. "Further study of cases that can successfully be treated with hormone- and immunotherapy, and how to identify them, will unlock this potential."
E-Scape Bio announced an extension of its Series A funding to a total of $63 million. Created as a spin-off from research conducted at the Gladstone Institutes, E-Scape Bio is a biopharmaceutical company with a mission to develop new therapies to treat neurodegenerative disorders such as Alzheimer's disease.
› Verified 8 days ago
| Entity Name | Texas Oncology Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811944101 PECOS PAC ID: 5395658934 Enrollment ID: O20031124000323 |
News Archive
Researchers at the Partners AIDS Research Center at Massachusetts General Hospital (PARC-MGH) may have discovered a second molecular "switch" responsible for turning off the immune system's response against HIV.
An international team of researchers led by scientists at the Virginia Bioinformatics Institute at Virginia Tech have sequenced the genome of an Amerindian strain of the gastric bug Helicobacter pylori, confirming the out-of-Africa migration of this bacterial stowaway to the New World. Experiments in animals have highlighted how specific genes in the bacterial strain may be crucial to the onset of inflammation and disease.
Contrary to popular belief, there is no connection between lunar phases and the incidence of psychological problems. This is the conclusion reached by a team of researchers directed by Professor Genevi-ve Belleville of Universit- Laval's School of Psychology after having examined the relationship between the moon's phases and the number of patients who show up at hospital emergency rooms experiencing psychological problems.
"Understanding cancer heterogeneity could further reduce chemo use," says cancer research expert Antonio Giordano, MD, PhD, Director of the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University. "Further study of cases that can successfully be treated with hormone- and immunotherapy, and how to identify them, will unlock this potential."
E-Scape Bio announced an extension of its Series A funding to a total of $63 million. Created as a spin-off from research conducted at the Gladstone Institutes, E-Scape Bio is a biopharmaceutical company with a mission to develop new therapies to treat neurodegenerative disorders such as Alzheimer's disease.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Angel E Mier Hicks, MD Po Box 911230, Dallas, TX 75391-1230 Ph: (972) 997-8000 | Angel E Mier Hicks, MD 5206 Research Dr, San Antonio, TX 78240-5251 Ph: (210) 595-5300 |
News Archive
Researchers at the Partners AIDS Research Center at Massachusetts General Hospital (PARC-MGH) may have discovered a second molecular "switch" responsible for turning off the immune system's response against HIV.
An international team of researchers led by scientists at the Virginia Bioinformatics Institute at Virginia Tech have sequenced the genome of an Amerindian strain of the gastric bug Helicobacter pylori, confirming the out-of-Africa migration of this bacterial stowaway to the New World. Experiments in animals have highlighted how specific genes in the bacterial strain may be crucial to the onset of inflammation and disease.
Contrary to popular belief, there is no connection between lunar phases and the incidence of psychological problems. This is the conclusion reached by a team of researchers directed by Professor Genevi-ve Belleville of Universit- Laval's School of Psychology after having examined the relationship between the moon's phases and the number of patients who show up at hospital emergency rooms experiencing psychological problems.
"Understanding cancer heterogeneity could further reduce chemo use," says cancer research expert Antonio Giordano, MD, PhD, Director of the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University. "Further study of cases that can successfully be treated with hormone- and immunotherapy, and how to identify them, will unlock this potential."
E-Scape Bio announced an extension of its Series A funding to a total of $63 million. Created as a spin-off from research conducted at the Gladstone Institutes, E-Scape Bio is a biopharmaceutical company with a mission to develop new therapies to treat neurodegenerative disorders such as Alzheimer's disease.
› Verified 8 days ago
Dr. Dennis Anthony Ruff, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 8307 Gault Ln, San Antonio, TX 78209 Phone: 210-798-5112 | |
Zarema J Singson, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5223 Hamilton Wolfe Rd, San Antonio, TX 78229 Phone: 210-614-1234 Fax: 210-614-0952 | |
Sapna Raghunathan, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 8300 Floyd Curl Dr, San Antonio, TX 78229 Phone: 210-450-9490 Fax: 210-450-6065 | |
Dr. Jonathan Edward Slovik, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4502 Medical Dr, San Antonio, TX 78229 Phone: 210-358-4000 Fax: 210-358-0647 | |
Mr. Paul Joseph Fanucchi, NP Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: Marianist Residence, 520 Fondham, San Antonio, TX 78228 Phone: 210-434-4157 Fax: 210-433-6005 | |
Socrates B Aramburu, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1100 Mccullough Ave, Suite 300, San Antonio, TX 78212 Phone: 210-271-3204 Fax: 210-222-2761 | |
David H White, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 6800 Ih 10 W, Ste 350, San Antonio, TX 78201 Phone: 210-616-0801 |